Pivotal Group Acquires Precision Science
Wednesday, November 18, 2026 · first reported by Private Equity Professional
Pivotal Group acquired Precision Science, a Phoenix contract manufacturer of pharmaceuticals, medicated feed additives and supplements for animal health companies. Pivotal plans to build an animal health platform starting with supplements and pharmaceuticals. Bryan Vincent is CEO of Precision Science.
- Firm
- Pivotal Group
- Also named
- Precision Science
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
- La Caisse leads talks for stake in Bain’s Bridge Data CentresPrivate Equity Wire
- CVC seeks to exit near-€3bn Irca deal with AdventPrivate Equity Wire
- Blackstone data centre REIT strikes $5bn AWS dealPrivate Equity Wire +4
- KKR Completes Sale of USI to AonPrivate Equity Professional +1
- KKR, Centennial sell Brisbane industrial park for $75.7mIREI
- CW Advisors adds $920m Boston-area RIAIREI
Got news? Send it to us →